Anti-emetics (10.03.2020) Flashcards
CINV
Chemotherapy induced nausea & vomiting (CINV)
- e.g. cisplatin
Treatment of CINV
Triple Therapy:
- Ondansetron - 5-HT3A receptor antagonist (used for early stage N&V)
- Glucocorticoids - reduce free radical production (used for late stage N&V)
- Aprepitant - neurokinin-1 receptor antagonist (used for late stage N&V)
Ondansetron
= 5-HT3A receptor antagonist
- 5-HT3A receptors are found on nerve fibres going to CTZ
- dansetron = 5HT receptor antagonist
Promethazine
- Promethazine - H1 receptor antagonist (expressed vestibular nuclei which are activated due to neural mismatch in motion sickness)
- used in motion sickness
- OTC
Hyoscine (scopolomine)
– non-selective muscarinic receptor antagonist
- centrally acting non-selective muscarinic receptor antagonist
- acts on CTZ and VC -> not only used for motion sickness but also in end-of-life care.
- SE: constipation, dizziness, drowsiness, dry mouth, dyspepsia…
Metoclopramide
Dual action
- Dopamine D2 receptor antagonist
- Prokinetic – stimulates gastric emptying
- Inhibits D2 receptors in CTZ
- 5-HT3A receptor antagonist
- Inhibits activation of CTZ
would be also good to treat drug induced N&V?
Pathophysiology of CINV
- chemotherapy agent (e.g. cisplatin) is toxic to cells and causes release fo free radicals leading to excessive 5HT release
- 5HT activates 5HT3A receptors on nerve fibres to chemoreceptor trigger zone (CTZ)
- CTZ activates nerve fibres going to the vomiting center (muscarinic receptors 1-5 at VC)
- activation of the VC causes N&V
What is vomiting
the forceful oral expulsion of gastric contents.
Neurokinin 1 receptor antagonists in CINV treatment
- neurokinin 1 R is found in area posterma of the VC
- activated by substance P (which is related from higher centres of the brain and is involved in pain perception)
- used for late N&V in CINV
- e.g. aprepitant
Biphasic response fo N&V
in CIMV
early N&V -> Ondansetron (5HT3A R antagonist)
late N&V -> GC and neurokinin-1 R antagonist
Pathophysiology of motion sickness
- Labyrinth - neural mismatch between what you see and what you feel -> activates histamine1 receptors on vestibular nuclei
- Vestibular nuclei activate muscarinic (M1-5) receptors on CTZ
- CTZ activates VC, which causes nausea
Where are the muscarinic receptors in the pathway that causes nausea?
- on the VC
- also on CTZ
- activation of the M1-5 muscarinic receptors -> N&V
Treatment of motion sickness
- Promethazine - H1 receptor antagonist
- Hyoscine (scopolomine) – non-selective muscarinic receptor antagonist
Gastroparesis
- delayed emptying of the stomach
- reduced stomach contraction
Pathophysiology of gastroparesis
- 5-HT – activates 5-HT3A receptors on CTZ
- CTZ activates nerves fibres to vomiting centre (VC)
- VC -> nausea